Laboratories play a pivotal role in clinical decision-making
IVD accounts for ~ 2 % of worldwide healthcare spending
IVD influences > 60 % of clinical decision-making
Increased value of Diagnostics
In vitro diagnostics (IVDs) have long been considered as the “silent champion” of healthcare, influencing over 60 % of clinical decision-making, while accounting for only about 2 % of total healthcare spending.
The role of IVDs is set to grow with today’s changes in healthcare. With the development of Personalized Healthcare (PHC), patients can now benefit from targeted treatments based on the presence of specific genetic defects or biomarkers in their blood or tissue. Targeted therapies and diagnostic tests that help to improve medical decision-making not only offer clinical benefits for patients but are also attractive through health economic benefits to regulatory authorities and payers.